FDA Grants Eltrombopag Breakthrough Therapy Designation for Severe Aplastic Anemia
February 4th 2014Eltrombopag (Promacta), a small molecule thrombopoietin receptor (TPOR) agonist, has received a Breakthrough Therapy designation from the FDA for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.
Study affirms importance of vaccination before exposure to HPV
January 7th 2014Canadian researchers led by Salaheddin M. Mahmud, MD, PhD of the University of Manitoba conducted a study to assess the effectiveness of the quadrivalent human papillomavirus (QHPV) vaccine against cervical dysplasia.
If You're Not at the Table, You're on the Menu
December 30th 2013To me, the statement means that no matter how much someone agreeing with you might try to represent you, having the unique experience of being you and being where decisions are made means volumes more. All too often, if you aren't part of the decision making, you will likely get left out, or worse yet, get served on the menu.